Study of the Annexin A1 and Its Associations with Carcinoembryonic Antigen and Mismatch Repair Proteins in Colorectal Cancer

详细信息    查看全文

• 作者：Lenuce Ribeiro Aziz Ydy…
• 关键词：Annexin A1 ; Mismatch repair proteins ; Carcinoembryonic antigen levels ; Colorectal tumor
• 刊名：Journal of Gastrointestinal Cancer
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：47
• 期：1
• 页码：61-68
• 全文大小：448 KB
• 参考文献：1.INCA—Instituto Nacional de Câncer: Estimativa de Câncer no Brasil. http://​www.​inca.​gov.​br (2016). Accessed 04 December 2015.
  2.Duncan R, Carpenter B, Main LC, Telfer C, Murray GI. Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer. 2008;98:426–33.PubMedCentral CrossRef PubMed
  3.Church JM. Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer. Ann Med. 1996;28(6):479–82.CrossRef PubMed
  4.Lecona E, Barrasa JI, Olmo N, Llorente B, Turnay J, Lizarbe MA. Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells. Role of p53, NF-Y, and p38 mitogen-activated protein kinase. Mol Cell Biol. 2008;28:4665–74.PubMedCentral CrossRef PubMed
  5.Sato Y, Kumamoto K, Saito K, Okayama H, Hayase S, Kofunato Y, et al. Up-regulated annexin A1 expression in gastrointestinal cancer is associated with cancer invasion and lymph node metastasis. Exp Ther Med. 2011;2:239–43.PubMedCentral PubMed
  6.Solito E, Christian HC, Festa M, Mulla A, Tierney T, Flower RJ, et al. Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface. FASEB J. 2006;20:1498–500.PubMedCentral CrossRef PubMed
  7.Sakaguchi M, Murata H, Sonegawa H, Sakaguchi Y, Futami J, Kitazoe M, et al. Truncation of annexin A1: a regulatory level for linking epidermal growth factor signaling with cytosolic phospholipase A2 in normal and malignant squamous epithelial cells. J Biol Chem. 2007;282:35679–86.CrossRef PubMed
  8.Damazo AS, Yona S, Flower RJ, Perretti M, Oliani SM. Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis. J Immunol. 2006;176:4410–8.PubMedCentral CrossRef PubMed
  9.Violette SM, King I, Browning JL, Pepunsky RB, Wallner BP, Sartorelli AC. Role of lipocortin 1 in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma. J Cell Physiol. 1990;142:70–2.CrossRef PubMed
  10.Solito E, de Coupade C, Parente L, Flower RJ, Russo-Marie F. Human annexin 1 is highly expressed during the differentiation of the human epithelial cell line a 549: involvement of NF-IL6 in phorbol ester induction of annexin 1. Cell Growth Differ. 1998;9:327–36.PubMed
  11.Leoni G, Alam A, Neumann PA, Lambeth JD, Cheng G, McCoy J, et al. Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. J Clin Invest. 2013;123:443–54.PubMedCentral CrossRef PubMed
  12.Solito E, Kamal A, Russo-Marie F, Buckingham JC, Marullo S, Perretti M. A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J. 2003;17:1546–56.
  13.De Coupade C, Gillet R, Bennoun M, Briand P, Russo-Marie F, Solito E. Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice. Hepatology. 2000;31:371–80.CrossRef PubMed
  14.Podgorki MR, Goulding NJ, Hall ND, Flower RJ, Maddison J. Autoantibodies to lipocortin-1 are associated with impaired glucocorticoid responsiveness in rheumatoid arthritis. J Rheumatol. 1992;19:1668–71.
  15.D’Acquisto F, Perretti M, Flower RJ. Annexin-A1: a pivotal regulator of the innate and adaptive immune systems. Br J Pharmacol. 2008;155:152–69.PubMedCentral CrossRef PubMed
  16.Gastardelo TS, Cunha BR, Raposo LS, Maniglia JV, Cury PM, Lisoni FC, et al. Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma. PLoS One. 2014;9, e111317.PubMedCentral CrossRef PubMed
  17.Queiroz CJ, Nakata CM, Solito E, Damazo AS. Relationship between HPV and the biomarkers annexin A1 and p53 in oropharyngeal cancer. Infect Agent Cancer. 2014;21:9–13.
  18.Gervaz P, Cerottini JP, Bouzourene H, Hahnloser D, Doan CL, Benhattar J, et al. Comparison of microsatellite instability and chromosomal instability in predicting survival of patients with T3N0 colorectal cancer. Surgery. 2002;131:190–7.CrossRef PubMed
  19.Grizzle WE, Shibata D, Manne U, Myers RB, Frost AR, Srivastava S, et al., editors. Molecular pathology of early cancer. Washington, DC: Ios Press; 1999.
  20.Wang JYJ, Edelmann W. Mismatch repair proteins as sensors of alkylation DNA damage. Cancer Cell. 2006;9:417–8.CrossRef PubMed
  21.Priolli DG, Cardinalli IZ, Piovesan H, Margarido NF, Martinez CAR. Proposta para estadiamento do câncer colorretal baseada em critérios morfofuncionais. correlação com níveis séricos do antígeno carcinoembrionário. Rev Bras Coloproct. 2007;27:374–83.CrossRef
  22.Pagé M, Dalifard I, Bertrand G, Bocquillon PG, Daver A. Immunostaining of colorectal cancer with monoclonal anti-CEA antibodies compared to serum and tumor CEA content. Anticancer Res. 1986;6:893–6.PubMed
  23.Lorenzi M, Vindigni C, Manacci C, Tripodi SA, Iroatulam A, Petrioli R, et al. Histopathological and prognostic evaluation of immunohistochemical findings in colorectal cancer. Int J Biol Markers. 1997;12:68–74.PubMed
  24.Bond CE, Umapathy A, Ramsnes I, Greco SA, Zhao ZZ, Mallitt KA, et al. p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers. Int J Cancer. 2012;130:1567–76.CrossRef PubMed
  25.Pinho MSL. Colorectal cancer with microsatellites instabilities: a different disease. Rev Bras Coloproct. 2002;22(2):139–44.
  26.Petrella A, Festa M, Ercolino SF, Zerilli M, Stassi G, Solito E, et al. Induction of annexin-1 during TRAIL-induced apoptosis in thyroid carcinoma cells. Cell Death Differ. 2005;12:1358–60.CrossRef PubMed
  27.Saito N, Qiao H, Yanagi T, Shinkuma S, Nishimura K, Suto A, et al. An annexin A1-FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions. Sci Transl Med. 2014;6, 245ra95.CrossRef PubMed
  28.Tarantino I, Warschkow R, Worni M, Merati-Kasani K, Köberle D, Schmied BM, et al. Elevated preoperative CEA is associated with worse survival in stage I–III rectal cancer patients. Br J Cancer. 2012;107:266–74.PubMedCentral CrossRef PubMed
  
• 作者单位：Lenuce Ribeiro Aziz Ydy (1)
  Gilmar Ferreira do Espírito Santo (2)
  Ivana de Menezes (1) (3)
  Michelle Santos Martins (4)
  Eliane Ignotti (1) (5)
  Amílcar Sabino Damazo (1) (6)
  
  1. Post-Graduate Program in Health Sciences, Faculty of Medicine (FM), Federal University of Mato Grosso (UFMT), 78060-900, Cuiabá, MT, Brazil
  2. Department of Surgery, Faculty of Medicine, UFMT, Cuiabá, MT, Brazil
  3. Laboratory of Pathology, Faculty of Medicine, University Hospital Júlio Muller, UFMT, Cuiabá, MT, Brazil
  4. Undergraduate Course in Medicine, Faculty of Medicine, UFMT, Cuiabá, MT, Brazil
  5. Department of Nursing, State University of Mato Grosso (UNEMAT), Cáceres, MT, Brazil
  6. Department of Basic Health Sciences, Faculty of Medicine (FM), Federal University of Mato Grosso (UFMT), 78060-900, Cuiabá, MT, Brazil
  
• 刊物主题：Oncology; Gastroenterology; Radiotherapy; Cancer Research; Internal Medicine;
• 出版者：Springer US
• ISSN：1941-6636

文摘

Purpose Annexin-A1 (ANXA1) has been implicated in various tumor types, but few studies have investigated its involvement in colorectal cancer. The study aimed to analyze ANXA1 expression in the normal margin and colorectal tumor tissues of 104 patients who underwent surgery for colorectal cancer and to associate the ANXA1 expression with predictive clinicopathological variables.